Navigation Links
Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration
Date:1/28/2011

ition of rights to intellectual property assets; market acceptance of our future products; government regulation of the pharmaceutical industry;  Endo's dependence on a small number of products; Endo's dependence on outside manufacturers for the manufacture of a majority of its products;  Endo's dependence on third parties to supply raw materials and to provide services for certain core aspects of its business; new regulatory action or lawsuits relating to Endo's or Qualitest's use of narcotics in many of its core products; Endo's and Qualitest's exposure to product liability claims, market withdrawals and product recalls and the possibility that Endo may not be able to adequately insure itself; the successful efforts of manufacturers of branded pharmaceuticals to use litigation and legislative and regulatory efforts to limit the use of generics and certain other products; Endo's ability to successfully implement its acquisition and in-licensing strategy; regulatory or other limits on the availability of controlled substances that constitute the active ingredients of some of its products and products in development; the availability of third-party reimbursement for our products; the outcome of any pending or future litigation or claims by third parties or the government, and the performance of indemnitors with respect to claims for which we have been indemnified; our dependence on sales to a limited number of large pharmacy chains and wholesale drug distributors for a large portion of its total revenues; a determination by a regulatory agency that Endo is engaging or has engaged in inappropriate sales or marketing activities, including promoting the "off-label" use of its products, the risk that demand for and acceptance of our products or services may be reduced; the risk of changes in governmental regulations; the impact of economic conditions; the impact of competition and pricing and other risks and uncertainties, including those detailed from time to
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government
3. JHP Pharmaceuticals and Putney Inc. Announce Multi-Year Contract Manufacturing Agreement
4. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
5. Amylin Pharmaceuticals Reports 2010 Financial Results
6. Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team
7. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
8. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
9. Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
10. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
11. Amylin Pharmaceuticals to Webcast Year-End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... In response to urgent requests from the Deputy Minister ... Leone , Direct Relief delivered two 10-bed medical tents ... of local health workers who contract Ebola while fighting the ... center was constructed for foreign health care workers who may ... local Sierra Leonean health workers. With ...
(Date:12/22/2014)... , Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), ... CytoSorb® blood purification technology to help fight deadly ... 28 countries worldwide, today announced the appointment of ... FACS, as its Senior Vice President of Clinical ... Dr. Di Russo is an accomplished ...
(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/h3xm6q/us ... Self-monitoring Blood Glucose Market" report to their offering. ... This market insight focuses on the developments in the ... States . Reimbursement analysis and the effects of ... more than 73 SMBG meters have been performed, based ...
Breaking Medicine Technology:First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5US Self-monitoring Blood Glucose Market 2
... Nov. 1, 2011 Luminex Corporation (NASDAQ: ... quarter ended September 30, 2011.  Financial and operating highlights ... ) Consolidated third quarter revenue was $45.6 ... 2010 Third quarter 2011 assay sales of $13.4 ...
... ALTO, Calif., Nov. 1, 2011 Jazz Pharmaceuticals, Inc. (Nasdaq: ... third quarter of 2011. Total revenues for ... to $44.8 million for the third quarter of 2010.  Total ... Adjusted net income for the third quarter of 2011 ...
Cached Medicine Technology:Luminex Corporation Reports Third Quarter 2011 Results 2Luminex Corporation Reports Third Quarter 2011 Results 3Luminex Corporation Reports Third Quarter 2011 Results 4Luminex Corporation Reports Third Quarter 2011 Results 5Luminex Corporation Reports Third Quarter 2011 Results 6Luminex Corporation Reports Third Quarter 2011 Results 7Luminex Corporation Reports Third Quarter 2011 Results 8Luminex Corporation Reports Third Quarter 2011 Results 9Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results 2Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results 3Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results 4Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results 5Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results 6Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results 7Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results 8Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results 9
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of ... its new selection of black one-shoulder cocktail dresses . ... they are available at discounted prices, up to 70% off. ... last for three weeks only. You know, we have thousands ... interested in our new items can visit our website for ...
(Date:12/25/2014)... Helen Harris’ RP (Retinitis Pigmentosa) International ... after an 8 year battle with breast cancer. ... in her home in Woodland Hills California after an ... , As the founder and volunteer President ... and championed many of today's greatest breakthroughs in restoring ...
(Date:12/25/2014)... is common during the holidays, but there are strategies that ... "Don,t arrive at a party hungry. It may seem logical ... a party, but deprivation leads to hunger, and hunger leads ... in Mount Kisco, N.Y., said in a hospital news release. ... even to have a snack before attending a party when ...
(Date:12/25/2014)... 2014 “ SmileStix ” was featured on ... latest and coolest mobile applications on the iOS, Android, and ... of NewsWatch, conducted the app review and shared with viewers ... stickers. , The old saying goes, “A picture says a ... that can describe a single image, because each picture holds ...
Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 2Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 3Health News:RP International founder, Helen Harris Dies on Christmas Eve Just Hours Before Her Holiday Television Broadcast to Raise Funds to Cure Blindness was Broadcasted Nationally 4Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... da Silva on Friday issued a compulsory license ... Merck's antiretroviral Efavirenz, the AP/Forbes reports. ... a "national emergency" and issue compulsory licenses on ... Brazilian Health Minister Jose Gomes Temporao late last ...
... Johns Hopkins Childrens Center neurologists are sounding the alarm for ... In fact, nearly 3,200 children have so-called brain ... permanent neurological damage, according to Lori Jordan, M.D. ... brain tumors, says Jordan, but unlike cancer, sadly, strokes ...
... SAARC Secretariat and UNICEF, experts and policy makers are ... to plan for the future of over 10 million ... becomes public knowledge, their children are likely to face ... health centers and in schools," said Frances Turner, deputy ...
... 15-year-old Indian-American boy underwent a simultaneous liver and kidney ... the attending doctors claimed as the first such in ... a disease known as primary Hyperoxaluria, in which the ... in the kidneys, bones, heart and pancreas. Patients suffering ...
... you row merrily down the Portland streams, think again. Scientists ... the national effort to narrow down on the main pollutants ... exercise by scientists found residues of medicines and coffee sediments ... likes of Prozac, Tagamet, Benadryl, and Micatin. Caffeine was also ...
... Bill Clinton has once again lent a helping hand to ... Brazil government and drug giant Merck over pricey anti-retroviral ... Clinching a deal with two Indian pharmaceutical companies Cipla and ... provide second-line AVR drugs and a next generation one-pill-a-day drug. ...
Cached Medicine News:Health News:Childhood Strokes Linked to Whiplash, Other Traumatic Injury 2Health News:NRI Boy Underwent a Rare Dual Transplant Surgery 2Health News:Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More 2
MD Coder Charge Capture Pocket PC Edition is a charge capture tool. We have integrated the feedback from hospitals and physicians. MD Coder Charge Capture supports both the Palm OS and Pocket PC plat...
... list of disease and code numbers in ... PC PDA or Smartphone. The International Classification ... is based on the World Health Organization's ... ICD-9-CM is the official system of assigning ...
The focus of HandEchart Professional is to offer a practical and basic electronic patient record keeping system that anyone can learn in minutes....
Archimedes is an innovative specialty calculator. Forget having to remember complicated formulas, just enter the values and out come the results....
Medicine Products: